Cite
MLA Citation
Eric R. Siemers et al.. “Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.” Alzheimer's & dementia, vol. 12, no. 2, 2016, pp. 110–120. http://access.bl.uk/ark:/81055/vdc_100102545434.0x000024